SCHEMBL9998384

SCHEMBL9998384

CC/C(=C\c1cccc(Cl)c1)C(OC(C)=O)OC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 1/20 0.42
PTGS2 P35354 1/20 0.41
FBP1 P09467 1/20 0.41
HPGD P15428 4/20 0.41
CYP2C19 P33261 1/20 0.41
AKR1C3 P42330 1/20 0.40
ALOX15 P16050 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
KCNA3 P22001 1/20 0.39
MAOB P27338 1/20 0.38
GRIK1 P39086 1/20 0.37
GRIK2 Q13002 1/20 0.37
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998385 1.00 KMT2A (0.43) KMT2AMEN1CYP1A2CYP2C9PTGS2
SCHEMBL9998028 0.89 CYP1A2 (0.40) KMT2AMEN1CYP1A2CYP2C9PTGS2
SCHEMBL9998027 0.89 CYP1A2 (0.40) KMT2AMEN1CYP1A2CYP2C9PTGS2
SCHEMBL9997881 0.84 LMNA (0.41) KMT2AMEN1PTGS2FBP1HPGD
SCHEMBL9997905 0.84 LMNA (0.41) KMT2AMEN1PTGS2FBP1HPGD
SCHEMBL9997934 0.84 ALDH1A1 (0.44) KMT2AMEN1CYP1A2CYP2C9FBP1
SCHEMBL9997932 0.84 ALDH1A1 (0.44) KMT2AMEN1CYP1A2CYP2C9FBP1
SCHEMBL9998493 0.84 CYP1A2 (0.45) KMT2AMEN1CYP1A2CYP2C9PTGS2
SCHEMBL9998495 0.84 CYP1A2 (0.45) KMT2AMEN1CYP1A2CYP2C9PTGS2
SCHEMBL9998362 0.83 CYP1A2 (0.42) KMT2AMEN1CYP1A2CYP2C9PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 KMT2A 2324/4885MEN1 1032/4885CYP1A2 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.